Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose -- Ignore unavailable to you. Want to Upgrade?

To: Shake-Man who wrote (757)	4/17/1998 1:17:00 AM
From: BIGFRED	Respond to of 4650

Hi XANAX: Unless the news is POSITIVE EPS, that means they have cash, or acquiring another 10% of Biomoda, or acquiring another company, or a huge order, I see a run up in the 30's and settling back down in the mid 20's. Just like it is doing now. If any of the above mentioned scenarios happens, we need to analyze the potential then. From the insider trading report, we see an intention of selling 400k shares. So, if am right, the shares will be sold in the next run up, adding them to the float and limiting its upside potential. Against what I just said above is two successive good news, two days apart for instance, which would send ADOT higher after the first run up. 6 weeks history: In the last 6 weeks we had 2 announcements by ADOT about a breakthrough from BIOMODA and another 2.7 million orders for BB. We touched 37 cents and came back down below 25 cents. We then had the pennywise recommendation which I believe got us to 35 cents. Two days ago, on Tuesday, there was a lot of selling and someone sold at .20 cents "to pop another". I picked up a whole bunch that day at 7/32. Today, though, the selling and buying was balanced. I placed a very small order at 7/32 that did not get filled. Last week I bought at .225. The reason I am accumulating in the low 20's is because, i believe we only closed under 20 cents for 4 or 5 days only. Now XANAX, the real potential is I believe next year, where Biomoda is anticipating to market the cancer testing kit by the end of the second quarter of 1999. As Louis Rukeyser would say:"no guarantee from management". Take care Fred